GW Pharmaceuticals (NASDAQ: GWPH) announced this morning that the European Commission has approved the marketing authorization for the company's plant-derived CBD-based epilepsy drug Epidyolex. Epidyolex was created to treat seizures... read more →
MKM Partners Issues Mixed Ratings & Price Targets on 8 Canadian and U.S. Pot Stocks U.S. based analyst Bill Kirk of MKM Partners initiated coverage on eight marijuana stocks this... read more →
Marijuana Stocks Trade Down, AGLC Puts CannTrust on Notice, MediPharm & Cronos Ink Deal, iAnthus Acquisition The Cannabis Catch-Up is a convenient and easy to read daily summary of the top cannabis stock... read more →
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana stock news stories for the week of September 9th – 15th, 2019. Without further ado,... read more →
This summer had cannabis stocks baked, and not in a good way. Overall market turmoil linked to global trade battles did not help the sector, and pot stocks got slammed... read more →
Investors Can Use This Pattern to Forecast Trend Reversals and Even Calculate Price Targets As the end of the most recent downswing in marijuana stocks nears its end, investors can... read more →
The Brand-New Marijuana ETF Will Become the 5th to List in the U.S. This Year The cannabis fueled party on Wall Street shows no signs of slowing down as yet... read more →
The Cannabis Catch-Up is a convenient and easy to read daily summary of the top cannabis stock news. We've scanned the newsfeeds of all the important marijuana stocks and put... read more →
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana stock news stories for the week of September 2nd - 8th, 2019. Without further ado,... read more →
Marijuana Stocks Soar Off the Bottom as Investors Eye Legalization 2.0 So far so good right? That's what the majority of cannabis investors are thinking right now regarding the start... read more →